2021 Global Sustainability Report summary 02 01 | About AmerisourceBergen Our COVID-19 response Our focus throughout the pandemic remains on prior itizing the we ll-being of o ur team members across the company and uphold ing the safety of the ph armaceutical supply chain while ensuring more tha n 4.5 m illion medications arrive where and when they are needed every da y. We have incre ased our efforts to support our partners, government agenc ies, and cu stomers in promoting vaccine education and increasing access to COVI D-19 vaccin es an d therapeutics, es peci ally for vulnerable populations globally exp erien cing ba rriers to care. Since the start of the pandemic, the AmerisourceBergen Foundation has provided $ 2 million to support our communities impacte d by COVI D-1 9 , including a donation of $700,000 to Boys & Girl s Clubs of America to support COVID-19 vaccine educat ion. “ B oys & Girls Clubs across the country serve as trusted thought leaders who play a critical role in supporting community education and understanding around COVID-19 safety measures and vaccines. Support from the AmerisourceBergen Foundation has enabled Clubs to expand upon this important work, from creating and distributing customized resources, to hosting educational events and serving as COVID-19 vaccination sites to help build equity and access to the vaccine. We are grateful that the AmerisourceBergen Foundation is committed to helping us build a path to a brighter future for all.” Jim Clark , President & CEO of Boys & Girls Clubs of America Other highlights include: • Allianc e Healthcare Norge Apotekdrift AS and Alliance Healthcare Norge AS made a donation to COVAX to support equitable vaccine distribution around the world • Cr eated equitable access to COVID-19 vaccines, delivering vaccines to 30+ countries worldwide • Suppor ted vaccination efforts with the Federal Retail Pharmacy program serving underserved patient populations through our Good Neighbor Pharmacy partners • Sinc e 2020, we have worked with the U.S. Department of Health and Human Services (HHS) to distribute COVID-19 therapies approved for Emergency Use Authorization (EUA). Since this partnership started, AmerisourceBergen has shipped over 3.6 million patient courses of COVID-19 therapies to sites of care throughout the United States